HBI Deals+Insights / M&A/IPOs
HBI spoke with John DiGiovanni, recently appointed Head of Healthcare at European mid-market private equity firm Inflexion. DiGiovanni discusses Inflexion’s healthcare strategy for 2026, trends in pharma services and medtech, and the broader market forces shaping its investment approach.





